![Pascal Touchon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Pascal Touchon
Directeur/Membre du Conseil chez
IPSEN
Fortune : 788 528 $ au 31/08/2026
Profil
Dr. Pascal Touchon is a Partner at Jeito Capital SASU and an Independent Director at MedinCell SA. He is on the Board of Directors at MedinCell SA and Ipsen SA. Dr. Touchon was previously employed as a Chairman by Atara Biotherapeutics, Inc. and a SVP-Global Head Cell & Gene by Novartis Oncology, Inc. He also served on the board at Dantari, Inc., Genoptix, Inc., Cogen Immune Medicine, Inc. and Navigate BioPharma Services, Inc. He received his MBA from INSEAD and a doctorate degree from Université Toulouse III - Paul Sabatier.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2025 | 77 955 ( 0,78 % ) | 693 800 $ | 31/08/2026 | |
IPSEN SA 0 % | 31/12/2025 | 500 ( 0 % ) | 94 728 $ | 31/08/2026 |
Postes actifs de Pascal Touchon
| Sociétés | Poste | Début |
|---|---|---|
| IPSEN | Directeur/Membre du Conseil | 01/10/2023 |
| MEDINCELL S.A. | Directeur/Membre du Conseil | 01/03/2025 |
Jeito Capital SASU
 Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Private Equity Investor | 01/06/2025 |
Anciens postes connus de Pascal Touchon
| Sociétés | Poste | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Directeur Général | 09/09/2024 |
Cogen Immune Medicine, Inc.
 Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Directeur/Membre du Conseil | 01/02/2020 |
Navigate Biopharma Services, Inc.
 Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Directeur/Membre du Conseil | - |
Dantari, Inc.
 Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Directeur/Membre du Conseil | - |
Genoptix, Inc.
 Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Directeur/Membre du Conseil | - |
Formation de Pascal Touchon
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
68
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Genoptix, Inc.
Genoptix, Inc. Medical/Nursing ServicesHealth Services Provides cancer laboratory testing services | Health Services |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
INSEAD
 INSEAD Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Toulouse III - Paul Sabatier
 Université Toulouse III - Paul Sabatier Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedinCell SA
 MedinCell SA Pharmaceuticals: MajorHealth Technology Provides therapeutic solutions | Health Technology |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Cogen Immune Medicine, Inc.
Cogen Immune Medicine, Inc. Pharmaceuticals: MajorHealth Technology Develops immune medicines | Health Technology |
Jeito Capital SASU
Jeito Capital SASU Investment ManagersFinance Jeito Capital is an active manager which seeks investment opportunities in companies located in Europe. The firm targets companies operating in the fields of biotech and biopharma. It provides financing for early stage capital requirements. | Finance |
Navigate Biopharma Services, Inc.
Navigate Biopharma Services, Inc. BiotechnologyHealth Technology Operates as a testing laboratory that designs biomarker solutions | Health Technology |
Dantari, Inc.
Dantari, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that engages in creating breakthrough medicines for the treatment of cancer and serious diseases | Health Technology |
